Credible Market has released a new market report titled, “Blood serum Market (by product, application, and region), Global Opportunity Analysis and Industry Forecast, 2021-2028”. The blood serum market is a competitive, and fragmented landscape with vast opportunities for new players, thanks to growing technological advancements in tissue culture, and diagnostic testing. Some key players in the blood serum market are, Sigma-Aldrich, Thermo Fisher, Corning, Merck, Gemini, Bioind, and Bovogen.
The global blood plasma market reached a robust valuation of $23,789 million in 2016. The blood plasma is a core component of various therapy, diagnostic, and medicinal research measure. The growing development of reagents for infectious diseases, and its key application in the area in times of the Covid-19 pandemic remains a major driver of growth for the blood plasma market. The growth in research areas like cell culture, thanks to growing advancements in pattern detections through machine learning, and visualization of 3D model also presents a promising horizon for growth for players in the blood serum market.
Get Sample Report: https://crediblemarkets.com/sample-request/blood-serum-market-243911
Key players in the global Blood Serum market covered in Chapter 4:
South Pacific Sera
Jin Yuan Kang
Thermo Fisher (Life-Tech)
In Chapter 11 and 13.3, on the basis of types, the Blood Serum market from 2015 to 2026 is primarily split into:
Bovine (Fetal Bovine, Newborn Calf, Calf, Adult Bovine)
In Chapter 12 and 13.4, on the basis of applications, the Blood Serum market from 2015 to 2026 covers:
Cell culture media
Cell line saving
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
Demand for Inactivated Vaccines for Covid-19 Remains a Major Prospect
Blood serum is an important ingredient for making inactivated vaccines around the world. Inactivated vaccines usually include deactivated pathogens, which help individuals created antibodies to fight off a virus. These vaccines are widely used for a variety of diseases including Hepatitis A, Polio, Flu, Rabies, and now even Covid-19. An Indian company, Bharat-Infotech has launched an inactivated covid-19 vaccine to immunise the large Indian population. More than 10 million doses of the Covishield vaccines have already been shipped. The vaccine relies on largely imported blood serum obtained from a new-born calf. Moreover, the prevalence of diseases like polio, regular vaccination drives for hepatitis A, and flu continue to drive robust growth for inactivated vaccines in the blood serum market globally.
Credible Markets has emerged as a dependable source for the market research needs of businesses within a quick time span. We have collaborated with leading publishers of market intelligence and the coverage of our reports reserve spans all the key industry verticals and thousands of micro markets. The massive repository allows our clients to pick from recently published reports from a range of publishers that also provide extensive regional and country-wise analysis. Moreover, pre-booked research reports are among our top offerings.
Credible Markets Analytics
99 Wall Street 2124 New York, NY 10005
Contact No: +1(929)-450-2887
Email: [email protected]